Damora Therapeutics, Inc. · NASDAQ:DMRA
Winslow Garrett sold 245 Damora Therapeutics, Inc. shares (Form 4)
Traded Jul 3 to Jul 6, 2026 · Filed Jul 7, 2026
From Jul 3 to Jul 6, 2026, Winslow Garrett (General Counsel) sold 245 Damora Therapeutics, Inc. shares at US$29.98 for US$7,345, leaving 2,289 shares. Filed Jul 7, 2026 (Form 4).
- Sold
- 245 shares
- Price
- US$29.98
- Value
- US$7,345
- Holding after
- 2,289 shares
- Trading plan
- No
- Role
- General Counsel
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 3, 2026 | Common Stock | Option exercise | 680 | 2,534 | Direct | |
| Jul 6, 2026 | Common Stock | Sale | 245 | US$29.98 | 2,289 | Direct |
Source
Related
- Damora Therapeutics, Inc.
- Winslow Garrett
- Damora Therapeutics, Inc. shareholders
- Form 4 · Jarrett Jennifer · Sep 28, 2026
- Schedule 13G · BlackRock, Inc. · Jul 28, 2026
- Schedule 13G · Avoro Capital Advisors LLC · May 15, 2026
- Schedule 13G/A · Jain Global LLC · May 15, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · May 15, 2026